Left main intervention: acute and late problems Alexander Loch - PowerPoint PPT Presentation
Left main intervention: acute and late problems Alexander Loch University Malaya Medical Centre Case 1. Acute problem Presentation 54yo male AMI ST elevation lateral leads History of multiple PCIs Diagnostics What to do?
Left main intervention: acute and late problems Alexander Loch University Malaya Medical Centre
Case 1. Acute problem
Presentation • 54yo male • AMI • ST elevation lateral leads • History of multiple PCIs
Diagnostics
What to do? Issues: late presentation LCX likely infarcted…. Any benefit opening LCX? PCI to LCX will jeopardize flow to LAD…. Likely messy… Options: 1. Leave it as it is? 2. Stent LAD as prognostically more important 3. Try to open LCX and be prepared for bifurcation stenting
What to do? Issues: late presentation LCX likely infarcted…. Any benefit opening LCX? PCI to LCX will jeopardize flow to LAD…. Likely messy… Options: 1. Leave it as it is? 2. Stent LAD as prognostically more important 3. Try to open LCX and be prepared for bifurcation stenting
Onyx 3.0 x 12 LMS LCX Runthrough into LCX POBA Trek 2.75 x 15
Biofreedom 3.0 xx 33 LMS LAD (Culotte)
Biomatrix 2.72 x 28 (prox LAD) Biomatrix 2.5 x 33 (mid-distal LAD)
Result Culotte LMS prior to FKB
FKB (Lacrosse 2.5x15 LAD / Trek 2.0x15 LCX)
Biomatrix Neoflex 3.5 8 in LMS Lacrosse 2.5 x 15 LAD and LCX
Accepted result
Lessons Case 1: Dissection LMS after FKB • Keep it simple • FKB can result in LMS dissection • Immediate diagnosis and remedial is key
Case 2. Acute and late problem
Presentation • 71 yo lady • Severe angina • Rejected CABG • For provisional LMS LAD
Scoreflex 2.75x15 LAD Ultimaster 3.0 x 24 in prox LAD Ultimaster 3.5 x 18 from LMS LAD
Plaque shift into oLCX
Reverse crush LCX LAD NC Trek 3.75 x 15 (LAD) / Ultimaster 3.0 12 (LCX) FKB (NC Euphoria 2.5 x 15 / 3.0 x 15) POT (Accuforce 4.0 x 8)
Final result
Happy?!
6 months later angina…
Sapphire NC 4.0 x 10 Re-wiring and IVUS. POBA / DEB LCX Biomatrix alpha 3.5 x 29
Lessons Case 3: Reverse crush for LCX compromise resulting in ISR • Expect SB occlusion - even if ostium not (very) diseased • Reverse crush is bailout option if size discrepancy branches • Crush leaves a lot of metal • High index suspicion for ISR (despite FKB, POT….) • Correction – simple provisional stent … so far so good
Case 3. Acute problem
Background • Pt with oLMS and RCA disease
Diagnostic images
Background • Attempted PCI LMS at another centre (no image record): – Pt developed bradycardia and APO when wiring LAD – Procedure abandoned – Referred for CABG – CTS declined as considered “too high risk” • For elective PCI oLMS
JL3.5 7F, IABP 34cc, venous sheath Runthrough : wiring from outside
POBA oLMS (Tazuna 2.5 x12) POBA oLMS (NSE Alpha 4.0 x 13)
Stent placement oLMS (Promus Premier 3.0 x 32) Stent inflation (Promus Premier 3.0 x 32) NC balloon oLMS (Accuforce 4.0 x 8)
Final result
Lessons Case 4: oLMS unprepared PCI attempt resulting in bradycardia /APO • Preparation is key • Tight ostial lesions: – IABP – Pacing sheath standby – Wiring from outside – do not engage guide – Fast inflations
Case 4. Late problem
• 47yo man • Textbook DK crush LMS bifurcation under IVUS – LAD Xience 4.0 x 23, – LCX Xience 4.0 x 18, – FKB 3.5 x15 NC trek in both LAD and LCX, – POT 5.0mm balloon
DK crush result
• Presents 16 months later with exertional chest pain
Diagnostic images
Volcano IVUS LCX : fully expanded stent, ISR and clot +++ at ostium Thrombuster 6F clot aspiration Euphora 3.5x 15 LMS LCX followed by Accuforce 4.0 x 15
Volcano IVUS LCX : fully expanded stent, clot +++ at ostium Thrombuster 6F clot aspiration Euphora 3.5x 15 LMS LCX followed by Accuforce 4.0 x 15 Clot spill over into LAD ostium after ballooning LCX
IVUS LAD: fully expanded stent, some clots Sequent please DEB 4.0 x 20 into LCX Euphora 3.5x 15 LMS LAD followed by Accuforce 4.0 x 15
Final result
Lessons Case 5: ISR after DK crush • Even “ideal” bifurcation stenting (DK Crush/IVUS guided) can develop early significant ISR • Low threshold for relook • Simple POBA will often do the job
Literature
• Registry data • 1,353 patients • early-generation drug-eluting stent (E-DES) • Contemporary drug-eluting stent (C-DES) • Primary endpoint MACE (composite of cardiac death or myocardial infarction, stent thrombosis, target lesion revascularization) • 3-year follow-up
• early clinical outcomes – provisional and planned 2-stent treatment strategies similar outcome • long-term follow-up ( 3 years) – rates of cardiac death, MI, and TLR more common with planned 2-stent (14.4% vs 21.2%, adjusted [HR] 0.51) • Strong benefit toward the 1-stent strategy
• At 3 years, MACE occurred in 49 patients the culotte group and in 17 patients in the DK crush group (cumulative event rates of 23.7% and 8.2%, respectively; p < 0.001),
• TLF within 1 year – in 26 patients (10.7%) assigned to PS – in 12 patients (5.0%) assigned to DK crush (hazard ratio: 0.42) true distal LM bifurcation lesions using a planned DK crush 2-stent strategy resulted in a lower rate of TLF at 1 year than a PS strategy
Overall summary • Acute complications include • arterial dissection • arrhythmias • acute vessel closures • Late complications include: • ISR and ST
Recommend
More recommend
Explore More Topics
Stay informed with curated content and fresh updates.